Picillin

Quick links to important sections

Picillin

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Picillin

What is Picillin? Definition and Pharmacological Classification

Property Description
Active ingredient Ampicillin
Pharmacological class beta-Lactam Antibiotic, Aminopenicillin
Origin Semi-synthetic penicillin
Common purpose Systemic resolution of bacterial infections
Forms Capsules, Tablets, Oral Suspension, Powder for Injection

Picillin is a specific pharmaceutical product containing the active substance Ampicillin, which is classified as a beta-Lactam antibiotic. This medication belongs specifically to the Aminopenicillin subclass, a key group of prescription-only agents used to eliminate susceptible bacterial infections. Ampicillin is chemically recognized as a semi-synthetic penicillin because its final molecular structure is derived through targeted modification of the natural penicillin nucleus. This modification grants the drug the property of being acid-stable, a characteristic that permits its absorption when taken orally, distinguishing it from older penicillin types.

Composition and General Therapeutic Purpose

Picillin is formulated as a single-ingredient product, containing only the active substance Ampicillin alongside necessary pharmaceutically inert excipients. Ampicillin's general therapeutic purpose is to provide systemic support by acting as a bactericidal agent—meaning it actively kills the microorganisms responsible for illness. This action is recognized for resolving the underlying bacterial cause of an infection. The World Health Organization (WHO) includes Ampicillin on its List of Essential Medicines, highlighting its importance in treating bacterial disease.

Available Forms and Administration Types

Picillin is produced in various dosage form(s) to ensure flexibility in clinical settings. The common preparations include solid oral forms like capsules and tablets, as well as a liquid oral suspension often used to facilitate administration in pediatric patients. The product is also available as a sterile powder for injection which is reconstituted into a solution. This range of forms ensures that the drug can be delivered through the appropriate route of administration, either oral or parenteral (intravenous or intramuscular), based on the severity and context of the patient's condition.

Regulatory References

  1. World Health Organization (WHO)
  2. WHO Essential Medicines List

What side effects are possible with Picillin?

Possible Side Effects and Safety Information

The following information is based strictly on authoritative government regulatory documents, detailing the official safety profile of Picillin.

Serious Adverse Reactions and Restrictions

Picillin is contraindicated in patients with a documented history of hypersensitivity or severe allergic reaction to any penicillin or other beta-lactam antibiotic (e.g., cephalosporins, carbapenems). The most serious documented risks are fatal hypersensitivity reactions, including anaphylaxis and severe cutaneous adverse reactions (SCAR) such as Stevens-Johnson syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms).

Clinically significant serious events also include Convulsions/Seizures, particularly in patients with impaired renal function or those receiving high doses, and severe Antibiotic-Associated Colitis (including Clostridium difficile-associated diarrhea or CDAD), which can occur during or after treatment.


Common and System-Organ Class Effects

Adverse reactions are formally categorized by frequency (e.g., Common, Uncommon, Rare) and the body system affected. Common reactions primarily involve Gastrointestinal Disorders, such as nausea, vomiting, and diarrhea.

Less common, but documented, effects are organized across various System-Organ Classes, including:

  • Skin and Subcutaneous Tissue Disorders (e.g., rash)
  • Blood and Lymphatic System Disorders (e.g., changes in white blood cell or platelet counts)
  • Nervous System Disorders (e.g., headaches, dizziness, seizures)

Population-Specific Safety Notes

The official labeling notes specific risks related to certain patient groups. Individuals with impaired renal function require dose reduction to minimize the risk of CNS toxicity, including seizures. Furthermore, use is generally not recommended in patients with infectious mononucleosis due to the high likelihood of developing a non-allergic rash.

Overdose and Emergency Response

The official regulatory documents detail specific signs and required actions concerning Picillin (Ampicillin) overdose. Overdose may present with documented gastrointestinal effects such as nausea, vomiting, and diarrhoea, alongside signs of systemic imbalance including electrolyte disorders and acidosis. More severe manifestations involve the Central Nervous System, characterized by altered consciousness, central nervous excitation, and potentially seizures or coma. The administration of very high doses, particularly in individuals with severely impaired renal function, is noted to increase the risk of these neurotoxic reactions and may lead to oliguric renal failure.

In the event of a suspected overdose, regulatory authorities mandate that patients seek immediate medical attention and contact a poison control center. Urgent medical intervention is required if an individual has collapsed, experienced a seizure, has trouble breathing, or cannot be awakened. The required procedural management begins with medication discontinuation. Treatment is officially defined as symptomatic and supportive, as no specific antidote is known. Hospital monitoring may be required to observe for signs of neurotoxicity and to assess renal function.

Therapeutic Uses of Picillin

What Picillin treats: Main Uses and Benefits

Picillin (Ampicillin) is considered relevant for use across several therapeutic domains to help manage acute bacterial infections and the symptoms associated with them. The medication is commonly applied in conditions presenting with acute episodes, including severe systemic infections like septicemia and bacterial meningitis; serious gastrointestinal issues such as Typhoid Fever and dysentery; and infections of the respiratory and genitourinary tracts, such as pneumonia and complicated UTIs.

This application assists with managing symptoms related to systemic imbalance, such as high fever and chills, and symptoms linked to organ-specific functional stress. By addressing the specific bacterial cause, Picillin may help interrupt the infectious process and supports the patient during difficult episodes by easing distress and helping to maintain comfort.

Picillin is often used during phases when symptoms become more noticeable and when supportive relief is appropriate.

The medication is also used in a preventative context (prophylaxis) in high-risk clinical scenarios, such as the peripartum period or prior to specific surgeries. This use assists with maintaining comfort and general well-being and may help reduce the risk of developing symptomatic disease.


Quick Fact: Relief for Acute Symptom Clusters

Picillin is relevant for managing symptoms that interfere with daily comfort, particularly when groups of symptoms, such as those involving high fever, acute diarrhea, or significant headaches, appear suddenly or escalate temporarily.

Eligibility and Restrictions for Use

Who Can and Cannot Use Picillin? Official Eligibility

The eligibility profile for Picillin (Ampicillin) is determined by regulatory agencies based on a patient's medical history and current physiological status.

Exclusion/Restriction Basis of Non-Eligibility
Absolute Contraindication A history of serious hypersensitivity reactions (e.g., anaphylaxis, SJS) to Picillin, any penicillin, or other beta-lactam antibacterial drugs [Source 1.1, 2.1].
Disease Exclusion Use is not recommended in patients with Infectious Mononucleosis (glandular fever) due to a high risk of developing a non-allergic skin rash [Source 1.1].

Eligibility is conditional for certain populations:

  • Organ Function: Patients with severe renal impairment require conditional use; dose modification or extension of the dosing interval is necessary to maintain eligibility [Source 2.1].
  • Age Groups: Use is established across adults and the pediatric population. However, use in neonates requires special consideration due to the immaturity of their renal function [Source 2.7].
  • Reproductive Status: Use during pregnancy is permitted only if clearly needed (Former FDA Category B). The medicine is excreted in trace amounts in breast milk, making use generally acceptable, though monitoring for the infant is advised [Source 3.2, 3.3].

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation identifies several clinically significant interaction patterns for Picillin (Ampicillin), which are classified based on their effect on the drug's exposure or action.

Documented Pharmacokinetic and Pharmacodynamic Interactions

Interacting Substance/Condition Official Interaction Pattern
Probenecid (Uricosuric Agent) Reduces the renal tubular secretion of Picillin, leading to significantly increased and prolonged blood concentrations of the antibiotic.
Bacteriostatic Antibiotics May interfere with the bactericidal effect of Picillin. Classes noted include Tetracycline, Erythromycin, and Chloramphenicol.
Allopurinol (Anti-gout Agent) Co-administration is documented to substantially increase the incidence of skin rashes.
Oral Contraceptives May reduce the efficacy of combined oral contraceptives by causing a transient decrease in the plasma concentration of estrogen hormones.

Restrictions and Administration Conditions

Administration of Picillin is formally contraindicated in patients with Infectious Mononucleosis due to the high, officially documented risk of a non-allergic skin rash. The absorption of oral Picillin is reduced by food; therefore, official labeling mandates that oral forms must be administered one hour before or two hours after meals to ensure effective drug exposure. Furthermore, injectable Picillin must not be physically mixed with aminoglycosides (e.g., Gentamicin) in the same syringe or IV fluid, as this causes the inactivation of the aminoglycoside component. Patients with renal impairment are noted to have altered clearance, which results in increased serum concentrations of Picillin.

Mechanism of Action

Mechanism of Action: Irreversible Cell Wall Inhibition

Picillin's active ingredient, Ampicillin, functions as an irreversible covalent inhibitor that acts selectively on the bacterial enzyme system. Its beta-lactam structure targets Penicillin-Binding Proteins (PBPs), a family of bacterial transpeptidases essential for maintaining the cell wall. Ampicillin mimics the natural substrate and forms a permanent chemical bond with the PBP active site, thereby halting the cross-linking of peptidoglycan polymers.

This molecular inhibition triggers the bactericidal cascade. The failure to construct a structurally stable cell wall prevents the susceptible bacterium from withstanding its own high internal osmotic pressure. This imbalance leads to the activation of bacterial autolytic processes and the subsequent lysis (rupture) of the cell. This destructive physiological consequence results in the active elimination of the microorganism.

The drug's action is subject to mechanistic constraints, primarily enzymatic inactivation. Bacteria producing beta-Lactamase enzymes can hydrolyze the drug’s beta-lactam ring, preventing the required covalent interaction with PBPs and rendering the mechanism ineffective.

Dosage and Administration Information

How to Use Picillin

Picillin, containing ampicillin, is administered according to specific principles to ensure consistent application in clinical practice. The routes of administration include oral (using capsules or suspension), intravenous (IV), and intramuscular (IM) injection. The parenteral routes (IV/IM) are typically reserved for moderate to severe infections.

Dosing and Frequency

Standard adult oral dosing typically ranges from 250 mg to 500 mg per dose, while parenteral doses can range up to 2 g per dose, with maximum daily limits up to 12 g total for severe infections. The total daily dose is typically divided and taken at fixed intervals, usually every 6 hours, though this may be shortened to every 4 hours in more severe contexts to maintain adequate levels of the medicine.

Administration Conditions

Oral Administration: Oral Picillin is taken on an empty stomach, meaning approximately 30 minutes before or 2 hours after a meal, consumed with water, to maximize absorption into the bloodstream.

Parenteral Administration: The powder for injection is reconstituted with an appropriate sterile diluent immediately before use. The resulting solution is administered within a short window, typically one hour of preparation. IV doses are typically given slowly, over 10 to 30 minutes.

Duration and Adjustments

Treatment generally continues for a minimum of 48 to 72 hours after the patient no longer shows symptoms. A minimum duration of 10 days is specified for certain types of infection. Dosage frequency is adjusted in cases of renal impairment based on creatinine clearance. If a dose is missed, it is typically taken as soon as remembered, unless it is nearly time for the next scheduled dose, in which case the missed dose is skipped; doubling the dose is not practiced.

Recent Clinical Evidence

Picillin: Recent Clinical Evidence

Picillin (a representative of the aminopenicillin class of beta-lactam antibiotics) is indicated for use against certain susceptible bacterial infections. Clinical studies have focused on its observed effects in treating a range of conditions, including specific upper respiratory, skin, and genitourinary tract infections, where it is often considered a first-line option.

Efficacy Data from Key Trials

Research has shown that Picillin exposure is associated with outcomes that include the resolution of infection symptoms in susceptible organisms. For example, a controlled trial comparing two aminopenicillins for acute ENT infections reported that the Picillin-type compound was observed to lead to a higher rate of symptom resolution by Day 14 compared to an earlier generation aminopenicillin. This finding suggests a potentially shorter average duration of symptoms in that specific patient group.

Additionally, Picillin, often in combination with a beta-lactamase inhibitor, has been investigated for effectiveness against resistant strains, such as certain Acinetobacter baumannii isolates. In the context of broader antibiotic stewardship, its established clinical role supports its inclusion in many standard treatment regimens, particularly for community-acquired infections where susceptibility data is often unavailable initially.

Tolerability and Safety Profile

Picillin's overall tolerability profile has been examined across various studies. The most frequently reported adverse events observed in patients taking oral aminopenicillins generally involve the gastrointestinal system, such as nausea and diarrhea, though these are typically mild and transient. Hypersensitivity reactions, including various rashes and, rarely, severe anaphylaxis, are possible with all beta-lactam antibiotics. Patients with a known history of severe allergy to any penicillin-class drug are generally advised to avoid this compound. Recent research has also focused on the safety and viability of 'delabeling' penicillin allergies in patients deemed to be at low risk, indicating a continuous effort to optimize its use while mitigating unnecessary avoidance.

Observation Category Summary of Evidence Findings
Symptom Resolution Higher observed rate of symptom resolution in an ENT infection study compared to an older aminopenicillin.
Antimicrobial Resistance Combination with beta-lactamase inhibitors extends activity against certain resistant pathogens.
Adverse Events The most common adverse events relate to the gastrointestinal system; hypersensitivity reactions, though rare, are a known class risk.

Frequently Asked Questions (FAQ)

Common questions about Picillin (FAQ)


Q: What kind of infections does Picillin treat?

Picillin is used to address certain susceptible bacterial infections, including those of the upper respiratory tract, skin, and genitourinary system, and is included in various standard treatment regimens. Official information indicates that the established clinical role and broad spectrum of activity support its inclusion in many standard treatment regimens.


Q: Is a mild rash a common reaction to Picillin?

While serious skin reactions are rare but possible with beta-lactam antibiotics, rash is listed among the documented adverse events in official labeling. It is important to note that the most common side effects involve the gastrointestinal system, such as nausea and diarrhea, while reactions involving the skin, such as a rash, are listed across various frequency categories in the official product information.


Q: What kind of research supports the use of Picillin?

Clinical studies have focused on Picillin's effects in treating various bacterial infections. Research evidence, according to regulatory summaries, supports its use by showing symptom resolution in susceptible organisms. Its established clinical role ensures it is included in many standard treatment regimens for community-acquired infections.


Q: How effective is Picillin, according to clinical trials?

Clinical trials have examined Picillin’s effectiveness by measuring outcomes like the resolution of infection symptoms. For example, a controlled trial observed outcomes such as a higher rate of symptom resolution compared to an older aminopenicillin in a specific patient group. Official documentation supports its use as a powerful bactericidal agent—meaning it actively kills the harmful microorganisms.


Q: Why is Picillin often prescribed as a first-line treatment?

The drug is widely used for several susceptible bacterial infections, as its established clinical role is supported by official guidance. This is due to its effectiveness against common community-acquired pathogens where immediate susceptibility data may be unavailable, contributing to its inclusion in many standard treatment guidelines.


Q: Do studies suggest Picillin is effective against resistant bacteria?

Studies indicate that Picillin alone is limited against bacteria that produce beta-lactamase enzymes. However, its activity can be extended against certain resistant strains, such as specific Acinetobacter baumannii isolates, when it is used in combination with a beta-lactamase inhibitor.


Q: How quickly does Picillin start working?

According to the official clinical pharmacology information, the drug starts its mechanism of action—inhibiting bacterial cell wall synthesis—once it reaches therapeutic levels in the body. For the intravenous route, peak concentrations in the bloodstream are generally attained immediately following the infusion.


Q: Is Picillin the same as Penicillin?

No, Picillin is a specific product containing the active ingredient Ampicillin. Ampicillin is classified as a semi-synthetic penicillin and belongs to the beta-lactam antibiotic family. It is chemically related to natural penicillin but has specific structural modifications that grant it properties like stability for oral absorption and a broader spectrum of activity.


Q: What is the difference between Picillin and Amoxicillin?

Both Picillin (Ampicillin) and Amoxicillin are part of the aminopenicillin class of antibiotics. A key distinguishing factor noted in official instructions is the administration condition: oral Picillin is typically instructed to be taken on an empty stomach for better absorption, while Amoxicillin can be taken with or without food.


Q: Can Picillin affect sleep?

The official prescribing information has reported general central nervous system (CNS) effects. Adverse events reported have included headache and fatigue, which may be indirectly related to sleep disturbance, though these are not classified among the most common effects. Severe CNS effects, such as convulsions, have been reported, particularly in patients with kidney impairment or high doses.


Q: Is Picillin safe for people with liver disease?

The official labeling notes that hepatic function (liver function) is subject to periodic monitoring in patients with existing hepatic impairment. Adverse effects related to the liver, including hepatitis and cholestatic jaundice, have been associated with the use of Picillin’s active ingredient.


Q: Why do official documents say Picillin should be used with caution in certain groups?

Regulatory documents advise caution primarily in groups where the drug's clearance or safety profile is altered. This includes individuals with impaired renal (kidney) function, where dose modification or extension of the dosing interval is necessary, as specified in official labeling. Caution is also advised against use in patients with infectious mononucleosis due to the high likelihood of developing a non-allergic rash.


Q: Why is Picillin sometimes prescribed for preventative reasons?

Regulatory documents indicate that the drug is appropriate for prophylactic use (preventative treatment) in specific clinical scenarios where there is a strong suspicion of bacterial infection risk. This is in alignment with its classification as an antibacterial drug to treat or prevent infections proven or strongly suspected to be bacterial.


Q: Is it normal to feel tired while taking Picillin?

Fatigue and malaise (a general feeling of discomfort) have been reported in the body system adverse reactions in less than 1% of patients during clinical trials. These effects are not classified among the 'most common' reactions, which primarily affect the gastrointestinal system.


Q: Is there a generic version of Picillin available?

Yes, Picillin’s active ingredient is Ampicillin, which is chemically defined as a semi-synthetic penicillin. Ampicillin is an established compound and is widely available in generic formulations, in addition to brand-name products.


Q: How is Picillin eliminated from the body?

According to the official clinical pharmacology section, Picillin's active ingredient is primarily excreted unchanged in the urine. In individuals with normal kidney function, a significant portion is eliminated this way within the first eight hours. The active compound also appears in the bile.


Q: Does Picillin affect blood sugar levels?

Official labeling indicates that in patients with diabetes, Picillin (Ampicillin) may cause a false-positive result when certain laboratory tests are used to check for sugar in the urine. This is a technical interference with the test itself and not a direct change in the patient's blood sugar level.


Q: Is the evidence for Picillin considered strong by regulatory bodies?

Picillin's active ingredient, Ampicillin, is included on the World Health Organization (WHO) List of Essential Medicines. This inclusion signifies its foundational importance and established role in treating bacterial disease globally, supported by extensive clinical experience and regulatory review.


Q: Why is professional monitoring mentioned for Picillin use?

In cases of prolonged therapy, or when high dosages are being administered, regulatory bodies recommend periodic evaluation of certain body systems. Specifically, the renal (kidneys), hepatic (liver), and hematopoietic (blood-forming) systems are monitored. This periodic evaluation is recommended by regulatory bodies to assess potential changes in these body systems.


Q: Can I take Picillin if I am allergic to other antibiotics?

Regulatory documents explicitly state that Picillin is contraindicated (not to be used) in patients with a history of serious allergic reactions or hypersensitivity to any penicillin or other beta-lactam antibacterial drugs (like cephalosporins). Official guidance emphasizes the need to gather information on prior allergies before the medication is prescribed.


Q: What distinguishes Picillin from other drugs in its class?

Picillin's active ingredient is a semi-synthetic penicillin, meaning it is chemically modified from the original penicillin structure. This modification makes the drug acid-stable, which is a crucial distinction that allows it to be effectively absorbed when taken orally, unlike older penicillin types.


Q: What kind of infections are Picillin not intended to treat?

Picillin is a prescription antibacterial drug and is therefore only indicated to treat bacterial infections. According to information for patients, it is not effective against viral infections, such as the common cold, flu, or other infections caused by viruses.


Q: Is it possible for Picillin to cause dizziness?

Yes, dizziness has been reported as an adverse reaction in the post-marketing experience with Picillin (Ampicillin). This effect is categorized under Nervous System Disorders in the official product information.

How should Picillin be stored and disposed of?

Storage and Disposal Instructions for Picillin (Ampicillin)

Picillin must be stored and disposed of according to official regulatory conditions, which vary by product form.


Required Storage Conditions

Dosage Form Required Storage Environment Stability and Protection Constraints
Capsules Store at room temperature in the original, tightly closed container. Keep away from excess heat and moisture; do not store in the bathroom.
Oral Suspension (Reconstituted) Store in the refrigerator (2 C to 8 C). Do not freeze; dispose of any unused portion after 14 days.
Powder for Injection Store dry powder at 20 C to 25 C (controlled room temperature). Reconstituted solution must be used immediately or within 24 hours under refrigeration.

All forms of Picillin must be kept out of the sight and reach of children.

Official Disposal Instructions

Expired or unused Picillin should be returned via a drug take-back program. If a program is unavailable, mix the medicine with an undesirable substance (like coffee grounds or dirt), place it in a sealed container, and discard it in household trash. Do not dispose of this medication by flushing it down a toilet or sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Picillin found in:

A-Z Index: